Back

From systemic adiposity to local epicardial adipose tissue targets: uncovering novel mechanisms and biomarkers in atrial fibrillation

30 August 2026 (17:15 - 18:00)
Organised by: Logo
Congress Presentation Part of: Mechanisms of arrhythmias and gender differences Coronary Artery Disease ESC2026 Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Mr Shengkang Huang

Beijing (China)

7 More presentations in this session

Presentation thumbnail
Mexiletine in drug-refractory ventricular arrhythmias: real-world effectiveness and tolerability
Doctor H. Santos Moreira (Porto, PT)
Abstract Slides
Presentation thumbnail
Accelerated biological aging increases the 10-year mortality risk in patients with coronary artery disease after percutaneous coronary intervention
Doctor M. Liu (Beijing, CN)
Abstract Slides
Presentation thumbnail
Mortality and device intervention in patients with a history of atrial fibrillation: a substudy of APPRAISE ATP
Professor G. Boriani (Modena, IT)
Abstract Slides
Presentation thumbnail
Sex differences in long-term arrhythmogenic and mortality outcomes in patients with hypertrophic cardiomyopathy: a 20-year longitudinal observational study
Doctor D. Silva (Rochester, US)
Abstract Slides
Presentation thumbnail
Immune-epicardial adiposity, associated with coronary artery disease, is modulated by semaglutide
Doctor J. Gonzalez Juanatey (Santiago de Compostela, ES)
Abstract Slides

Access the full session

Session thumbnail
Mechanisms of arrhythmias and gender differences

The Event

Event poster

ESC Congress 2026

30 August 2026 17:15 CET
You may be interested in
thumbnail
Congress Presentation
Epicardial adipose tissue and its association with atrial fibrillation in middle-aged patients without overt heart disease
10 May 2023
thumbnail
Congress Presentation
Nation-wide GWAS meta-analysis reveals new genetic locus for early-onset atrial fibrillation
29 August 2025
thumbnail
Congress Session
Lipids and adipose tissue interaction in cardiovascular disease
30 August 2024
thumbnail
Congress Presentation
In-silico insights into the role of patient-specific fibrosis in personalised therapy selection for atrial fibrillation
1 September 2025

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources